Connor, Clark & Lunn Investment Management (CC&L)
BTAI icon

Connor, Clark & Lunn Investment Management (CC&L)’s BioXcel Therapeutics BTAI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BTAI Stock Details BTAI Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,091
Closed -$206K – 1227
2022
Q3 		$206K Buy
+1,091
New +$206K ﹤0.01% 990